Spectra Optia Apheresis System

DEVICE3 trials

Sponsors

Terumo BCT, University of Chicago

Conditions

Immune-related Adverse EventMultiple MyelomaMyeloproliferative DiseaseThrombocythemiaThrombocytosis

Unknown Phase

Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure

CompletedNCT01292486

Terumo BCTMultiple Myeloma

Start: 2011-02-28End: 2011-12-31Updated: 2013-05-01

Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions

CompletedNCT02308787

Terumo BCTMyeloproliferative Disease, Thrombocythemia, Thrombocytosis

Start: 2014-11-30End: 2015-05-31Updated: 2016-06-15

Pharmacokinetic Study of Therapeutic Plasma Exchange

Not yet recruitingNCT07756242

University of ChicagoImmune-related Adverse Event

Start: 2026-11-01End: 2028-02-01Target: 15Updated: 2026-08-10